Skip to content

Study · Case report or series · n = 1 · 2025

1 result

Hepatotoxicity induced by MK-677.

Cobani E, Amin MS, Hasso M, Kumbar L

BMJ case reports17 Jul 2025

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesSafety outcome

    In a previously healthy man, transaminitis developed after 2 months of MK‑677 use and liver tests normalized after withdrawal.

    In plain wordsA previously healthy man developed elevated liver enzymes after taking MK‑677 for 2 months. His liver tests normalized after he stopped MK‑677.

    Outcome
    IncreaseTransaminitis
    Study

    n = 1

    Outcome group
    Liver fat and liver function · Liver
    Studied dose
    Dose not stated · 2 monthsAs given in this study (human).

    Source sentences

    Summary
    Here we present the case of an otherwise healthy man in his early 30s, who developed transaminitis after consuming MK-677 for 2 months before presentation.
    Summary
    Liver function tests eventually returned to normal limits after stopping the supplement.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.